The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced cutting-edge technologies to tackle the growing threat of substandard and falsified medical products in Nigeria
Speaking at a sensitisation workshop in Kano, the NAFDAC Director-General outlined three key initiatives. Professor Mojisola Adeyeye was represented by the agency’s Director of Post-Marketing Surveillance, Mr Bitrus Fraden. These initiatives aim to safeguard public health—the GreenBook, Traceability Project, and Paediatric Regulation 2024.
The GreenBook is an innovative digital tool designed to help consumers easily identify and avoid counterfeit or substandard products. The Traceability Project establishes a robust legal framework. It tracks pharmaceutical products throughout the supply chain. This ensures their authenticity and safety.
Meanwhile, the Paediatric Regulation 2024 addresses the unique medical needs of children. It ensures that paediatric medicines meet stringent safety and efficacy standards.
“With these technological advancements, stakeholders can proactively detect fake medical products. They can also prevent their infiltration into the supply chain,” Professor Adeyeye stated. She added that the workshop aimed to equip healthcare providers with essential knowledge. The training also targeted manufacturers and wholesalers to effectively combat counterfeit drugs.
As counterfeiters employ increasingly sophisticated methods, NAFDAC is strengthening its efforts through technology-driven solutions and enhanced stakeholder collaboration. The agency has previously implemented several measures. These include consumer safety publications. They also introduced public warnings on counterfeit products via newspapers and television. In addition, social media awareness campaigns have been used to educate the public.
NAFDAC’s Northwest Zone Director, Mr Fraden Mullah, acknowledged that the region has issues. It is particularly challenging in Kano, which remains a hotspot for counterfeit and substandard medical products. He emphasised that detecting and classifying fake medicines remains a significant challenge. He further warned that NAFDAC has the legal authority to prosecute offenders. Penalties can range from product seizures and business closures to the revocation of licences.
Professor Adeyeye stressed that the fight against counterfeit medical products requires a collective effort beyond regulatory enforcement. She urged pharmacists, medical professionals, and drug distributors to support NAFDAC’s initiatives. This support ensures that Nigerians have consistent access to safe, high-quality, and effective medicines.